The Tyson Foods employee health plan administered by BlueAdvantage recognizes the key role that oncology practices play in the delivery of quality cancer care. We also recognize the challenges you face both in keeping current with treatment advances and ensuring affordable care for your patients. To support high-quality, high value care, we are pleased to announce new collaboration with Carelon Medical Benefits Management. Beginning January 1, 2018, we require your participation in the Carelon Medical Oncology Program for our members receiving chemotherapy for the treatment of cancer.

To identify an included member, look for the Tyson logo on a member’s BlueAdvantage ID card.

Benefits to your practice

• Synchronization with plan medical policy. All prescribed regimens are reviewed in real time for benefit coverage under plan medical policy.
• Actionable information. When your practice prescribes a cancer treatment regimen for an eligible member and submits it to Carelon for review, the prescribed regimen is compared against a comprehensive library of current, evidence-based Carelon Cancer Treatment Pathways. If the planned regimen is not aligned with a Carelon Pathway, information on evidence-based alternative regimens may be presented for your review. Pathway adherence will be tracked to understand prescribing patterns and regional treatment variation.
• Enhanced reimbursement. By choosing Carelon Cancer Treatment Pathways regimens when clinically appropriate, your practice may be eligible for enhanced reimbursement*.

* Participating providers in Arkansas, California, Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri, Nevada, New Hampshire, New York, Ohio, Virginia or Wisconsin may be eligible for enhanced reimbursement.